NLRP3 and type 2 diabetes mellitus: In conclusion, this study revealed that T2D induces increased microglial pyroptosis by activating the RAGE-ROS-NLRP3 axis, and then blocks remyelination after SCI, which strongly suggests that microglial pyroptosis may be the key target for treating T2D combined with SCI.